SciClone Pharmaceuticals Inc (SCLN)

10.56
NASDAQ : Health Care
Prev Close 10.41
Day Low/High 10.41 / 10.72
52 Wk Low/High 6.47 / 15.03
Avg Volume 454.40K
Exchange NASDAQ
Shares Outstanding 49.91M
Market Cap 519.55M
EPS 0.60
P/E Ratio 19.28
Div & Yield N.A. (N.A)

Latest News

Today's Weak On High Volume Stock: SciClone Pharmaceuticals (SCLN)

Today's Weak On High Volume Stock: SciClone Pharmaceuticals (SCLN)

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a weak on high relative volume candidate

SciClone Pharmaceuticals (SCLN): Today's Weak On High Volume Stock

SciClone Pharmaceuticals (SCLN): Today's Weak On High Volume Stock

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a weak on high relative volume candidate

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Oil controls the market, and Cramer is watching stocks to see which you should be buying.

'Mad Money' Lightning Round: Con Ed, Regeneron Are My Picks

'Mad Money' Lightning Round: Con Ed, Regeneron Are My Picks

Cramer is no fan of J.C. Penney and says NCR is up too much.

Interesting SCLN Put And Call Options For May 20th

Interesting SCLN Put And Call Options For May 20th

Investors in SciClone Pharmaceuticals, Inc. saw new options become available this week, for the May 20th expiration.

Commit To Purchase SciClone Pharmaceuticals At $7.50, Earn 12.2% Annualized Using Options

Commit To Purchase SciClone Pharmaceuticals At $7.50, Earn 12.2% Annualized Using Options

Investors considering a purchase of SciClone Pharmaceuticals, Inc. shares, but tentative about paying the going market price of $9.74/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Bullish Two Hundred Day Moving Average Cross - SCLN

Bullish Two Hundred Day Moving Average Cross - SCLN

In trading on Friday, shares of SciClone Pharmaceuticals, Inc. crossed above their 200 day moving average of $8.58, changing hands as high as $8.93 per share.

SciClone Pharmaceuticals Becomes Oversold (SCLN)

SciClone Pharmaceuticals Becomes Oversold (SCLN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Insider Trading Alert - MW, SCLN And ATHN Traded By Insiders

Insider Trading Alert - MW, SCLN And ATHN Traded By Insiders

Stocks with insider trader activity include MW, SCLN and ATHN

Commit To Purchase SciClone Pharmaceuticals At $10, Earn 26.9% Annualized Using Options

Commit To Purchase SciClone Pharmaceuticals At $10, Earn 26.9% Annualized Using Options

Investors considering a purchase of SciClone Pharmaceuticals, Inc. shares, but tentative about paying the going market price of $10.01/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ADT, AIN, BDBD, CBS.A, CRAY, EGT, FPRX, GERN, HMPR, ISIL, SCLN Downgrades: ASM, BRS, SRDX Initiations: DPLO, W Read on to get TheStreet Quant Ratings' detailed report:

SciClone Pharmaceuticals (SCLN) Flagged As Strong On High Volume

SciClone Pharmaceuticals (SCLN) Flagged As Strong On High Volume

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a strong on high relative volume candidate

Oversold Conditions For SciClone Pharmaceuticals (SCLN)

Oversold Conditions For SciClone Pharmaceuticals (SCLN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

SciClone Pharmaceuticals (SCLN) Flagged As Strong On High Volume

SciClone Pharmaceuticals (SCLN) Flagged As Strong On High Volume

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a strong on high relative volume candidate

SciClone Pharmaceuticals is Now Oversold (SCLN)

SciClone Pharmaceuticals is Now Oversold (SCLN)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Purchase SciClone Pharmaceuticals At $7.50, Earn 14% Annualized Using Options

Commit To Purchase SciClone Pharmaceuticals At $7.50, Earn 14% Annualized Using Options

Investors considering a purchase of SciClone Pharmaceuticals, Inc. shares, but cautious about paying the going market price of $8.50/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BECN, EGT, EMKR, LDR, PAR Downgrades: CIA, CJJD, CNP, ENDP, EVTC, FLR, FPRX, FRED, NTAP, OLED, SCLN, SLAB, XON, ZGNX Initiations: LMCK, LPG Read on to get TheStreet Quant Ratings' detailed report:

SciClone Pharmaceuticals (SCLN) Stock: Weak On High Volume Today

SciClone Pharmaceuticals (SCLN) Stock: Weak On High Volume Today

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a weak on high relative volume candidate

Trade-Ideas: SciClone Pharmaceuticals (SCLN) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: SciClone Pharmaceuticals (SCLN) Is Today's Weak On High Relative Volume Stock

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a weak on high relative volume candidate

Trade-Ideas: SciClone Pharmaceuticals (SCLN) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: SciClone Pharmaceuticals (SCLN) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a strong on high relative volume candidate

SciClone Pharmaceuticals (SCLN) Strong On High Relative Volume Today

SciClone Pharmaceuticals (SCLN) Strong On High Relative Volume Today

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a strong on high relative volume candidate

Buy These 6 Risky Pharmaceutical Stocks for Big Upside Potential

Buy These 6 Risky Pharmaceutical Stocks for Big Upside Potential

Looking to add even more performance to your portfolio? Consider pharmaceutical stocks with so-called high beta - a common measurement of volatility.

Insider Trading Alert - SANW, STRZA And SCLN Traded By Insiders

Insider Trading Alert - SANW, STRZA And SCLN Traded By Insiders

Stocks with insider trader activity include SANW, STRZA and SCLN

Strong On High Relative Volume: SciClone Pharmaceuticals (SCLN)

Strong On High Relative Volume: SciClone Pharmaceuticals (SCLN)

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a strong on high relative volume candidate

SciClone Pharmaceuticals (SCLN): Today's Weak On High Volume Stock

SciClone Pharmaceuticals (SCLN): Today's Weak On High Volume Stock

Trade-Ideas LLC identified SciClone Pharmaceuticals (SCLN) as a weak on high relative volume candidate

Commit To Buy SciClone Pharmaceuticals At $7.50, Earn 10.2% Annualized Using Options

Commit To Buy SciClone Pharmaceuticals At $7.50, Earn 10.2% Annualized Using Options

Investors considering a purchase of SciClone Pharmaceuticals, Inc. stock, but cautious about paying the going market price of $8.92/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Insider Trading Alert - JAZZ, ARE And SCLN Traded By Insiders

Insider Trading Alert - JAZZ, ARE And SCLN Traded By Insiders

Stocks with insider trader activity include JAZZ, ARE and SCLN